Neuralink Secures $650 Million In Series E Funding Round

Neuralink announced on Monday that it has closed a $650 million Series E funding round. With this new investment, Elon Musk’s company plans to expand patient access and develop more advanced devices.

According to the Neuralink’s announcement, the funding round included the participation of key investors such as Sequoia Capital, Thrive Capital, G42, ARK Invest, and DFJ Growth.

“We’re excited to announce our $650M Series E fundraising,” wrote the company in a post on the social media platform X. “We’re building technology to transform people’s lives: helping restore autonomy to those with motor, speech, or vision impairment by enabling them to control computers and robotic arms with their minds, output verbal thought as text, and generate visual perception.”

Neuralink explained that it aims to develop advanced technologies to enhance the connection between biological and artificial intelligence.

“This funding helps us bring our technology to more people—restoring independence for those with unmet medical needs and pushing the boundaries of what’s possible with brain interfaces,” states the document.

According to TechCrunch, in 2023, Neuralink raised $280 million in a Series D round, followed by an additional $43 million a few months later, funding that helped the company achieve several milestones.

Neuralink stated that its notable achievements since 2023 include treating multiple patients with severe paralysis—who are now using the company’s chips to control digital and physical devices—, launching clinical trials in multiple countries, developing new applications such as the CONVOY initiative, and getting the FDA Breakthrough Device Designation.

The company has also been developing its brain studies to expand its chip interactions with neural connections, as well as with more regions of the brain.

Last year, Neuralink showcased multiple success cases as well as challenges encountered. During a livestream on Musk’s social media platform X, a quadriplegic patient played chess controlling his moves with his brain. After a second implant, another patient was able to design 3D objects with computer-aided design (CAD) and play video games. The company also acknowledged mechanical problems with its brain chip implants, as several threads of the brain implant had retracted from the patient’s brain.